Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Classement en actions #32454
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Prix de l'action
$0.04367217
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$10.06M
Changement (1 jour)
3.99%
Changement (1 an)
-26.77%
Pays
SE
Échange IDL Diagnostics AB (publ) (IDLDX)

Catégorie

Historique du prix de l'action pour IDL Diagnostics AB (publ) (IDLDX)
Prix de clôture le plus élevé : $0.04 le 2026-08-01

Prix de clôture le plus bas : $0.66 le 2011-05-01
Historique du prix de l'action de IDL Diagnostics AB (publ) de 2011 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 6.57%
2025 9.67%
2024 -12.09%
2023 -20.98%
2022 -57.24%
2021 -56.70%
2020 105.13%
2019 -47.78%
2018 -46.79%
2017 -31.41%
2016 -39.64%
2015 56.69%
2014 -37.92%
2013 65.83%
2012 40.59%
2011 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$586.41 20.28%
US
$202.37 -3.18%
US
$24.18 79.18%
CN
$314.26 95.01%
US
$544.68 -14.61%
US